Stockholm, Sweden — Synact Pharma AB (”SynAct” eller ”Bolaget”) today announces that the company will present at the ABGSC Life Science Summit on May 19, 2022. The company will be represented by Chairman Dr. Torbjørn Bjerke
The presentation will be available after the meeting on Synact Pharmas website; www.synactpharma.com.
The information was submitted, through the agency of the contact persons below, for publication on May 18, 2022.
For additional information, please contact:
Jeppe Øvlesen, CEO, +45 28 44 75 67, [email protected]
Patrik Renblad, CFO, +46 707 47 97 68, [email protected]